Wei Zhang
- Obstetrics and Gynecology top 0.2%
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 36
- Cancer-related molecular mechanisms research 32
- MicroRNA in disease regulation 26
- Cancer, Hypoxia, and Metabolism 14
- Oncology top 1%
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 105
- RNA modifications and cancer 51
- Cancer-related gene regulation 29
- Infectious Diseases top 1%
-
- Liver Disease Diagnosis and Treatment 15
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Zhang
353 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Obstetrics and Gynecology 1.9k
- Cancer Research 1.9k
- Oncology 1.8k
- Molecular Biology 4.2k
- Infectious Diseases 1.0k
Countries citing papers authored by Wei Zhang
This map shows the geographic impact of Wei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zhang more than expected).
Fields of papers citing papers by Wei Zhang
This network shows the impact of papers produced by Wei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zhang. The network helps show where Wei Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 20 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 11 | |
| 9 | 2020 | 25 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 78 | |
| 13 | 2019 | 73 | |
| 14 | 2019 | 23 | |
| 15 | 2019 | 5 | |
| 16 | 2017 | 81 | |
| 17 | 2014 | 65 | |
| 18 | Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified. | 2013 | 21 |
| 19 | 2012 | 64 | |
| 20 | 2009 | 35 |
About Wei Zhang
Wei Zhang is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 373 papers that have together received 10.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (105 papers), RNA modifications and cancer (51 papers), Cancer Genomics and Diagnostics (36 papers), Cancer-related molecular mechanisms research (32 papers), Cancer-related gene regulation (29 papers), MicroRNA in disease regulation (26 papers), Liver Disease Diagnosis and Treatment (15 papers) and Cancer, Hypoxia, and Metabolism (14 papers). The work is most often cited by research in Obstetrics and Gynecology (1.9k citations), Cancer Research (1.9k citations) and Oncology (1.8k citations). Wei Zhang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yuanzhen Zhang, Dongchi Zhao, Juanjuan Guo, Xuechen Yu, Huixia Yang, Jing Liao, Dan Xu, Qing Gong, Chen Wang and Jiafu Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.